Boston Scientific (NYSE:BSX) experienced a 6% decline in stock price over the last quarter, amid a period of market uncertainty driven by new tariffs imposed by the U.S. and retaliatory measures from ...

Valued at a market cap of $134.1 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets medical ...

Boston Scientific Corp. closed 12.60% below its 52-week high of $107.17, which the company achieved on February 5th.

In the latest trading session, Boston Scientific (BSX) closed at $93.67, marking a +1.11% move from the previous day. Boston Scientific (NYSE:BSX) experienced a 6% decline in stock price over the ...

Truist lowered the firm’s price target on Boston Scientific (BSX) to $113 from $120 and keeps a Buy rating on the shares as part of a broad ...

It has been about a month since the last earnings report for Boston Scientific (BSX). Shares have lost about 4% in that time frame, outperforming the S&P 500. Will the recent negative trend ...

A diversified portfolio, strategic acquisitions, and aggressive R&D have driven Boston Scientific's recent revenue ... 12% organic growth in Q4, benefiting from increased adoption of the AGENT ...

Craft beverage specialist Boston Beer (NYSE:SAM) reported mixed fourth-quarter and full-year 2024 results on Tuesday, Feb. 25. Net revenue of $402.3 million beat expectations of $389 million ...

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and ...